Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,165 | -229,378 | -173,614 | -114,251 | -57,785 |
| Depreciation Amortization | -39 | 4,187 | 3,938 | 2,932 | 1,514 |
| Accounts payable and accrued liabilities | 1,223 | -1,813 | -2,098 | 1,204 | -2,507 |
| Other Working Capital | -11,204 | -1,738 | 1,250 | -10,653 | -7,532 |
| Other Operating Activity | 6,196 | 41,710 | 31,222 | 18,463 | 12,827 |
| Operating Cash Flow | $-52,989 | $-187,032 | $-139,302 | $-102,305 | $-53,483 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,737 | -560 | -9,141 | 13,411 | 8,597 |
| PPE Investments | N/A | -410 | -308 | -277 | -157 |
| Other Investing Activity | -15 | -65 | -50 | -35 | -20 |
| Investing Cash Flow | $8,722 | $-1,035 | $-9,499 | $13,099 | $8,420 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,903 | -5,806 | -2,903 | 0 | 0 |
| Common Stock Issued | 367 | 122,896 | 122,866 | 742 | 721 |
| Financing Cash Flow | $-2,536 | $117,090 | $119,963 | $742 | $721 |
| Exchange Rate Effect | 72 | -517 | -1,152 | -687 | -154 |
| Beginning Cash Position | 111,973 | 183,467 | 183,467 | 183,467 | 183,467 |
| End Cash Position | 65,242 | 111,973 | 153,477 | 94,316 | 138,971 |
| Net Cash Flow | $-46,731 | $-71,494 | $-29,990 | $-89,151 | $-44,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,989 | -187,032 | -139,302 | -102,305 | -53,483 |
| Capital Expenditure | N/A | -410 | -308 | -277 | -157 |
| Free Cash Flow | -52,989 | -187,442 | -139,610 | -102,582 | -53,640 |